VERUMICRO

Veru Inc.

HealthcareBiotechnology
$3.01
$0.00(+2.38%)
52W$2.06
$7.33
Updated Jun 29, 02:00 AM
RSI53
RS Rating73/99
Beta2.13
Volatility113%
F-Score2/9
Mkt Cap$48M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Veru Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 73), indicating performance broadly in line with the market. Earnings growth of 76% provides fundamental context to the price action. Investors should exercise caution due to high volatility (113% annualized), which requires wider risk management.

Relative Strength
73
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
2.13
vs S&P 500
HIGH BETA
52W Position
18%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.55
50 SMA > 100 SMA$2.48
100 SMA > 150 SMA$2.46
150 SMA > 200 SMA$2.72

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.97+1.33%ABOVE
50 SMA$2.55+17.91%ABOVE
100 SMA$2.48+21.51%ABOVE
150 SMA$2.46+22.35%ABOVE
200 SMA$2.72+10.58%ABOVE

Price Performance

1D+2.4%
1W+1.7%
1M+30.3%
3M+35.0%
6M+25.4%
YTD+32.6%
1Y-54.0%
3Y-33.6%
52-Week Trading Range18% from low
$3.01
52W Low$2.06
52W High$7.33

Technical Indicators

RSI (14)NEUTRAL
53.0
305070
Setup ScoreCOOL
5/10
Base depth: 175.1%

Risk Profile

Beta
2.13
52W Vol
113%
ATR
$0.26
Max DD (1Y)
-68%

Volume Analysis

Today
50D Avg
2.32M
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q3'25+33%
$-0.50
Q4'25+115%
$0.09
Q1'26+19%
$-0.26
Q2'26+76%
$-0.13
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-100.00%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+63.42%

Stock Price CAGR

10 Years:-13.34%
5 Years:-48.97%
3 Years:-33.64%
1 Year:-54.05%

Return on Equity

10Y Avg:-65.6%
5Y Avg:-96.0%
3Y Avg:-139.0%
Last Year:-53.4%

Key Metrics

Market Cap$48M
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is VERU in an uptrend right now?

VERU has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is VERU overbought or oversold?

VERU's RSI (14) is 53. The stock is in neutral territory, neither overbought nor oversold.

Is VERU outperforming the market?

VERU has a Relative Strength (RS) Rating of 73 out of 99. VERU is performing about average compared to the market.

Where is VERU in its 52-week range?

VERU is trading at $3.01, which is 41% of its 52-week high ($7.33) and 18% above its 52-week low ($2.06).

How volatile is VERU?

VERU has a Beta of 2.13 and 52-week volatility of 113%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.